ALS scientific breakthrough: Diabetes drug metformin shows promise in mouse study for a common type of ALS

arrow down
An FDA-approved diabetes drug shows early signs of promise against the most common genetic form of amyotrophic lateral sclerosis, a devastating neurological condition that causes paralysis.
Scroll to Top